The Food and Drug Administration (FDA) announced on Monday (November 10) that hormone replacement therapies for menopause will no longer carry a black box warning . This decision comes after a thorough review of scientific evidence, indicating that previous warnings about risks such as breast cancer, heart attack, and stroke were based on outdated data. According to FDA Commissioner Marty Makary , the warnings discouraged many women from using hormone therapy despite its benefits.

Hormone therapies, which replace estrogen and progesterone, are commonly used to alleviate menopause symptoms like hot flashes, mood swings, and bone fractures. They are available in various forms, including pills, patches, and creams. The FDA's updated labeling will apply to products containing estrogen or

See Full Page